Softgels have emerged as a versatile dosage form, yet they are often overlooked. It’s unique ability to improve bioavailability, enhance patient compliance, and accommodate diverse formulations positions well as a platform for market launches. Additionally, they play a strategic role in post-approval lifecycle conversions, offering opportunities to optimize product positioning and meet evolving market demands.
This webinar will explore the role of softgels in both early-stage and post-approval lifecycle management strategies. Industry experts will discuss key considerations for launching with softgels, opportunities for post-approval switches to or from softgels, and considerations when evaluating softgels versus other dose forms. Attendees will gain practical insights into the decision-making process and learn how to leverage softgel technology to enhance product value throughout its lifecycle.
Key Takeaways:
- Explore the strategic role of softgels in lifecycle management, including launch and post-approval scenarios
- Understand key considerations for transitioning between softgels and other dosage forms to maximize return on investment (ROI) for a drug.
- Gain insights into examples of lifecycle management strategies using softgel capsules.